Company: USCB
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0000927089-25-000082
Chunk: 27

Company: USCB FINANCIAL HOLDINGS, INC.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 27
---
 |
| Bernardo Fernandez(4)  |     |      90,000 |     |        10,000 |     | --             |     |   100,000 |
| Robert E. Kafafian(5)  |     |      55,000 |     |        45,000 |     | --             |     |   100,000 |
| Aida Levitan(6)        |     |      90,000 |     |            -- |     | --             |     |    90,000 |
| Ramon A. Rodriguez(7)  |     |     105,000 |     |            -- |     | --             |     |   105,000 |
| W. Kirk Wycoff(8)      |     |     100,000 |     |            -- |     | --             |     |   100,000 |

_____________________________

| (1) | Represents annual retainer for membership on our Board and the fee for serving as chair of the nominating and corporate governance committee. |

| (2) | Represents annual retainer for membership on our Board. |

| (3) | Represents annual retainer for membership on our Board. |

| (4) | Represents annual retainer for membership on our board and the fee for serving as chair of the loan committee; a portion of his annual retainer was paid through the grant of shares of restricted stock. |

| (5) | Represents annual retainer for membership on our Board and the fee for serving as chair of the asset-liability committee; a portion of his annual retainer was paid though the grant of shares of restricted stock. |

| (6) | Represents annual retainer for membership on our Board. |

| (7) | Represents annual retainer for membership on our Board and the fee for serving as chair of the audit and risk committee. |

| (8) | Represents annual retainer for membership on our Board and the fee for serving as chair of the compensation committee. |

| (9) | Messrs. Fernandez and Kafafian were granted restricted stock awards covering 940 and 4,229 shares, respectively. These amounts represent the aggregate grant date fair value of the restricted stock awards granted during the year ended December 31, 2024, in accordance with FASB ASC Topic 718. The assumptions used for calculating the grant date fair value are set forth in Note 9 of our consolidated financial